The $17 billion contract research organization (CRO) market is growing 15% annually. CROs currently perform approximately 25% of preclinical drug testing for pharmaceutical manufacturers, and analyst Isaac Ro of Leerink Swann predicts that, due to imminent strains on pharmaceutical firms including lower profits and more regulations, within three years the number will double to 50%. […]
New money is flowing to US government agencies, following President Bush’s signing of a supplemental funding bill on June 30. The bill allocated $400 million in new funding to four federal agencies: the National Institutes of Health (NIH) ($150 million), the National Science Foundation (NSF) ($62.5 million), the National Air and Space Administration ($62.5 million) […]
Since the end of last year, it has been clear that capital expenditures by the semiconductor industry have been falling significantly. The first half of 2008 has done nothing to mitigate this pessimism and, if anything, the situation has grown more dire than originally expected. This was the general business climate that set the stage […]
Company Announcements Hitachi High-Technologies reported Life Sciences Segment sales for the year ended March 31 increased 3.1% to ¥96.173 billion ($959.9 million), representing 10.2% of company revenues. Biotechnology-related equipment (including LC and spectrophotometers) accounted for 22% of Segment sales, clinical analyzers represented 66% and other products represented 12%. The company announced it is focusing on […]
According to the European Chemical Industry Council (Cefic), EU chemical production will increase 2.0% in both 2008 and 2009, following 2007 growth of 2.1%. Production of six subsectors (pharmaceuticals, petrochemicals, consumer chemicals, chemicals, basic inorganics and specialty chemicals) is set to either remain the same or increase in 2009, excluding polymers, for which output is […]
Particle bombardment technology, also known as biological biolistics or bioballistics, is a nonviral, physical gene delivery method in which target cells are transfected using DNA-coated particles. Cornell University horticultural scientist John Sanford and cohorts developed the technique in the early 1980s. The technology is a very effective gene delivery method for plant cells, as it […]
Santa Clara, CA 7/24/08—Affymetrix has purchased a developer of digitally encoded microparticle technology for $25 million in cash. GenomeWeb.com reports that the company is True Materials and that Randy True, the company’s vice president of R&D, has joined Affymetrix. Affymetrix stated that the technology will allow it to enter the low to mid-multiplexing markets and […]
San Diego, CA 7/22/08—Illumina has acquired Avantome, the developer of a long read-length sequencing technology, for $25 million in cash and contingent payments of up to $35 million. Avantome’s principal founders Mostafa Ronaghi and Helmy Eltoukhy will join Illumina. Dr. Ronaghi will serve as senior vice president and chief technical officer and Dr. Eltoukhy will […]
Company Announcements Dynisco restructured in March, creating divisions to serve specific market segments, including Plastics, Rubber and Industrial, Oil and Gas, Life Sciences, and Test and Control. Under an OEM agreement, Digital Light will supply REOLOGICA with photocuring accessories. In April, Anton Paar GmbH announced the appointment of Dr. Othmar Ederer, general director of the […]
Austin, TX 7/7/08—Xenemetrix announced that on June 15 it acquired Jordan Valley’s Analytical Instrument Division, which suppliers energy dispersive–X-ray fluorescence spectroscopy instruments (ED-XRF). Xenemetrix was formed by a private management group, led by CEO Doron Reinis, a founding partner of Business Processes, a consulting, production engineering and industrial engineering services firm. “As Jordan Valley Semiconductors […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
